Lineage Cell Therapeutics, Inc. | ||||
ASE : LCTX || Location: United States | ||||
$1.4+0.09 (+6.87%) |
1.33 M | 1.28 - 1.47 | ||
Last Updated:America/New_York | Volume | Day range |
Short Interest
Short Date | Short Interest |
---|---|
Feb. 29, 2024 | 9.623 M |
Feb. 15, 2024 | 10.036 M |
Jan. 31, 2024 | 8.455 M |
Jan. 12, 2024 | 7.881 M |
Dec. 29, 2023 | 6.936 M |
EPS Surprise
Period | Estimate | Actual | Surprise |
---|---|---|---|
12/31/2023 | -0.04 | -0.03 | 31.35% |
09/30/2023 | -0.04 | -0.04 | 8.47% |
06/30/2023 | -0.05 | -0.03 | 33.63% |
03/31/2023 | -0.04 | -0.03 | 23.27% |
12/31/2022 | -0.04 | -0.03 | 20.84% |
Sector | Healthcare | Industry | Biotechnology |
Shares Outstanding | 188.534M | Shares Float | 139.571M |
Short Float | 9.623M | Market Cap | 263.95M |
Institution ownership | 43.96% | Insider ownership | 4.131% |
Earnings Date | 05/09/2024 AMC | Cash Per Share | ? |
Trailing EPS | -0.12 | Forward EPS | -0.13 |